A higher basal activation status was detected in platelets from high anti-CCP2+ RA patients, as indicated by an increased expression of P-selectin (RA patients 7.94 ± 1.25% vs control 1.86 ± 0.82; p < 0.05) (Figure 4A). This evidence concerns the gene AGBL2 and rheumatoid arthritis.